A prospective, randomized, parallel-group, open label, non-inferiority, multicenter trial of a 12 month vs. a short-term platelet function testing guided prasugrel therapy in acute coronary syndrome patients undergoing coronary stenting
Latest Information Update: 21 Oct 2021
At a glance
- Drugs Prasugrel (Primary) ; Clopidogrel
- Indications Acute coronary syndromes; Cardiovascular disorders; Myocardial infarction; Stroke
- Focus Therapeutic Use
- Acronyms TROPICAL-ACS
- 15 Oct 2021 Results of meta-analysis from three clinical studies: TOPIC, TALOS-AMI and TROPICAL-ACS published in the American Journal of Cardiovascular Drugs
- 12 Jun 2019 Results of a pre-specified exploratory analysis assessing platelet reactivity and clinical outcomes in acute coronary syndrome patients treated with prasugrel and clopidogrel published in the European Heart Journal
- 29 Jan 2019 Results of a pre-specified analysis assessing the phenomenon of diurnal variability of on-clopidogrel versus on-prasugrel platelet reactivity in invasively managed ACS patients, published in the Thrombosis and Haemostasis